China Resources Pharmaceutical Group Ltd. (640) Stock Statistics & Valuation Metrics

China Resources Pharmaceutical Group Ltd. has a market cap or net worth of EUR 3.31B. The enterprise value is EUR 173.67B.

Market Cap

EUR 3.31B

Enterprise Value

EUR 173.67B

China Resources Pharmaceutical Group Ltd. has 6,282,510,300 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

6,282,510,300

Owned by Insiders

―

Owned by Institutions

4.22%

China Resources Pharmaceutical Group Ltd.’s return on equity (ROE) is 0.08 and return on invested capital (ROIC) is 4.73%.

Return on Equity (ROE)

0.08

Return on Assets (ROA)

0.01

Return on Invested Capital (ROIC)

4.73%

Return on Capital Employed (ROCE)

0.09

Revenue Per Employee

3.57M

Profits Per Employee

53.60K

Employee Count

84,000

Asset Turnover

0.94

Inventory Turnover

5.20

The current PE Ratio of China Resources Pharmaceutical Group Ltd. is 6.18. China Resources Pharmaceutical Group Ltd.’s PEG ratio is 0.11.

PE Ratio

6.18

PS Ratio

0.09

PB Ratio

0.48

Price to FCF

1.62

Price to Operating Cash Flow

1.39

PEG Ratio

0.11

In the last 12 months, China Resources Pharmaceutical Group Ltd. had revenue of 300.01B and earned 4.50B in profits. Earnings per share was 0.72.

Revenue

300.01B

Gross Profit

49.53B

Operating Income

13.90B

Pretax Income

13.13B

Net Income

4.50B

EBITDA

18.55B

Earnings Per Share (EPS)

0.72

In the last 12 months, operating cash flow was 20.97B and capital expenditures -2.96B, giving a free cash flow of 18.01B billion.

Operating Cash Flow

20.97B

Free Cash Flow

18.01B

Free Cash Flow per Share

2.87

China Resources Pharmaceutical Group Ltd. pays an annual dividend of ―, resulting in a dividend yield of 4.96%

Dividend Per Share

―

Dividend Yield

4.96%

Payout Ratio

N/A

Free Cash Flow Yield

61.86%

Earnings Yield

16.08%

Beta

0.32

52-Week Price Change

-5.50%

50-Day Moving Average

0.48

200-Day Moving Average

0.50

Relative Strength Index (RSI)

58.48

Average Volume (3m)

21.45K

China Resources Pharmaceutical Group Ltd. upcoming earnings date is ―, Before Open (Confirmed).

Last Earnings Date

Aug 24, 2026

Next Earnings Date

―

Ex-Dividend Date

―

China Resources Pharmaceutical Group Ltd. as a current ratio of 1.42, with Debt / Equity ratio of 183.14%

Current Ratio

1.42

Quick Ratio

1.11

Debt to Market Cap

3.72

Net Debt to EBITDA

4.70

Interest Coverage Ratio

6.33

In the past 12 months, China Resources Pharmaceutical Group Ltd. has paid 2.38B in taxes.

Income Tax

2.38B

Effective Tax Rate

0.18

China Resources Pharmaceutical Group Ltd. EV to EBITDA ratio is 6.22, with an EV/FCF ratio of 6.21.

EV to Sales

0.36

EV to EBITDA

6.22

EV to Free Cash Flow

6.21

EV to Operating Cash Flow

5.33

China Resources Pharmaceutical Group Ltd. has EUR 44.03B in cash and marketable securities with EUR 114.17B in debt, giving a net cash position of -EUR 70.14B billion.

Cash & Marketable Securities

EUR 44.03B

Total Debt

EUR 114.17B

Net Cash

-EUR 70.14B

Net Cash Per Share

-EUR 11.17

Tangible Book Value Per Share

EUR 15.44

Gross margin is 16.36%, with operating margin of 4.21%, and net profit margin of 1.53%.

Gross Margin

16.36%

Operating Margin

4.21%

Pretax Margin

4.35%

Net Profit Margin

1.53%

EBITDA Margin

5.86%

EBIT Margin

4.29%

The average price target for China Resources Pharmaceutical Group Ltd. is EUR 0.74, which is 11.43% higher than the current price. The consensus rating is Strong Buy

Price Target

EUR 0.74

Price Target Upside

44.55% Upside

Analyst Consensus

Strong Buy

Analyst Count

5

Revenue Growth Forecast

0.35%

EPS Growth Forecast

42.46%

Smart Score

6

AI Score

―